Thomas Trimarchi, President and CFO at BridgeBio Pharma, Inc. (BBIO), sold 84,474 shares at $49.48 ($4.2M) on 2025-08-21, disclosed to the SEC on 2025-08-22.
Open-market sale of $4.2M BBIO by President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.48 | 42,237 | $2.1M | 50.0% |
| 2 | $49.48 | 42,237 | $2.1M | 50.0% |
| Total | $49.48 avg | 84,474 | $4.2M | 100% |
| Filing → |
| BBIO | SELL | 2025-11-18 | $2.3M | — | Filing → |
| BBIO | SELL | 2025-08-19 | $1.7M | — | Filing → |